These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 9671334

  • 21. Anemia of cancer patients: patient selection and patient stratification for epoetin treatment.
    Ludwig H, Fritz E.
    Semin Oncol; 1998 Jun; 25(3 Suppl 7):35-8. PubMed ID: 9671328
    [Abstract] [Full Text] [Related]

  • 22. Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy.
    Witzig TE, Silberstein PT, Loprinzi CL, Sloan JA, Novotny PJ, Mailliard JA, Rowland KM, Alberts SR, Krook JE, Levitt R, Morton RF.
    J Clin Oncol; 2005 Apr 20; 23(12):2606-17. PubMed ID: 15452187
    [Abstract] [Full Text] [Related]

  • 23. Role of epoetin in the management of anaemia in patients with lung cancer.
    Morère JF.
    Lung Cancer; 2004 Nov 20; 46(2):149-56. PubMed ID: 15474662
    [Abstract] [Full Text] [Related]

  • 24. Effect of epoetin alfa on survival and cancer treatment-related anemia and fatigue in patients receiving radical radiotherapy with curative intent for head and neck cancer.
    Hoskin PJ, Robinson M, Slevin N, Morgan D, Harrington K, Gaffney C.
    J Clin Oncol; 2009 Dec 01; 27(34):5751-6. PubMed ID: 19884550
    [Abstract] [Full Text] [Related]

  • 25. Epoetin alfa use in gynecology. Past, present and future.
    Bachmann GA.
    J Reprod Med; 2001 May 01; 46(5 Suppl):539-44. PubMed ID: 11396388
    [Abstract] [Full Text] [Related]

  • 26. Associations of anemia, treatments for anemia, and survival in patients with human immunodeficiency virus infection.
    Sullivan P.
    J Infect Dis; 2002 May 15; 185 Suppl 2():S138-42. PubMed ID: 12001035
    [Abstract] [Full Text] [Related]

  • 27. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
    Phair JP, Abels RI, McNeill MV, Sullivan DJ.
    Arch Intern Med; 1993 Dec 13; 153(23):2669-75. PubMed ID: 8250662
    [Abstract] [Full Text] [Related]

  • 28. Impact of epoetin alfa in chemotherapy-associated anemia.
    Jilani SM, Glaspy JA.
    Semin Oncol; 1998 Oct 13; 25(5):571-6. PubMed ID: 9783596
    [Abstract] [Full Text] [Related]

  • 29. Epoetin alfa improves quality of life in anemic HCV-infected patients receiving combination therapy.
    Pockros PJ, Shiffman ML, Schiff ER, Sulkowski MS, Younossi Z, Dieterich DT, Wright TL, Mody SH, Tang KL, Goon BL, Bowers PJ, Leitz G, Afdhal NH, PROACTIVE Study Group.
    Hepatology; 2004 Dec 13; 40(6):1450-8. PubMed ID: 15565613
    [Abstract] [Full Text] [Related]

  • 30. Anemia in the setting of cancer and human immunodeficiency virus.
    Levine AM.
    Clin Infect Dis; 2003 Dec 13; 37 Suppl 4():S304-14. PubMed ID: 14581999
    [Abstract] [Full Text] [Related]

  • 31. Darbepoetin alfa: new indication/new dosage. No proven advantage in chemotherapy-induced anaemia.
    Prescrire Int; 2005 Oct 13; 14(79):174-6. PubMed ID: 16285072
    [Abstract] [Full Text] [Related]

  • 32. Epoetin alfa and epoetin beta: new indication. Treatment of anaemia due to cytotoxic chemotherapy.
    Prescrire Int; 2002 Apr 13; 11(58):39-43. PubMed ID: 11987310
    [Abstract] [Full Text] [Related]

  • 33. Epoetin alfa as a supportive measure in hematologic malignancies.
    Straus DJ.
    Semin Hematol; 2002 Oct 13; 39(4 Suppl 3):25-31. PubMed ID: 12447849
    [Abstract] [Full Text] [Related]

  • 34. Use of epoetin alfa in critically ill patients.
    Pajoumand M, Erstad BL, Camamo JM.
    Ann Pharmacother; 2004 Apr 13; 38(4):641-8. PubMed ID: 14966258
    [Abstract] [Full Text] [Related]

  • 35. Epoetin alfa. Clinical evolution of a pleiotropic cytokine.
    Henry DH, Bowers P, Romano MT, Provenzano R.
    Arch Intern Med; 2004 Feb 09; 164(3):262-76. PubMed ID: 14769622
    [Abstract] [Full Text] [Related]

  • 36. A new induction schedule of epoetin alfa 40.000 IU in anemic patients with advanced lung cancer.
    Ariganello O, Mancuso A, Di Molfetta M, Diana F, Beccaglia P, Cortesi E, De Marinis F.
    Lung Cancer; 2004 Oct 09; 46(1):119-24. PubMed ID: 15364140
    [Abstract] [Full Text] [Related]

  • 37. Epoetin alfa 60,000 U once weekly followed by 120,000 U every 3 weeks increases and maintains hemoglobin levels in anemic cancer patients undergoing chemotherapy.
    Patton J, Kuzur M, Liggett W, Miranda F, Varsos H, Porter L.
    Oncologist; 2004 Oct 09; 9(1):90-6. PubMed ID: 14755018
    [Abstract] [Full Text] [Related]

  • 38. Efficacy and safety analysis of epoetin alfa in patients with small-cell lung cancer: a randomized, double-blind, placebo-controlled trial.
    Grote T, Yeilding AL, Castillo R, Butler D, Fishkin E, Henry DH, DeLeo M, Fink K, Sullivan DJ.
    J Clin Oncol; 2005 Dec 20; 23(36):9377-86. PubMed ID: 16361638
    [Abstract] [Full Text] [Related]

  • 39. Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa.
    Lefebvre P, Vekeman F, Sarokhan B, Enny C, Provenzano R, Cremieux PY.
    Curr Med Res Opin; 2006 Oct 20; 22(10):1929-37. PubMed ID: 17022852
    [Abstract] [Full Text] [Related]

  • 40. Epoetin alfa and high-dose chemotherapy.
    Henry DH.
    Semin Oncol; 1998 Jun 20; 25(3 Suppl 7):54-7. PubMed ID: 9671332
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.